(Q37896522)

25 August 2017

1 reference

title

Metabolic syndrome: its history, mechanisms, and limitations (English)

1 reference

25 August 2017

1 reference

Eiji Oda

1

1 reference

25 August 2017

1 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

49

1 reference

25 August 2017

2

1 reference

25 August 2017

89-95

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-011-0309-6

25 August 2017

0 references

cites work

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

The metabolic syndrome as a concept of adipose tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Relation of body fat distribution to metabolic complications of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Insulin resistance and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Visceral obesity without insulin resistance in late-onset obesity rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Comparison among body mass index (BMI), waist circumference (WC), and percent body fat (%BF) as anthropometric markers for the clustering of metabolic risk factors in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Body mass index is more strongly associated with hypertension than waist circumference in apparently healthy Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Metabolic syndrome is independently associated with microalbuminuria in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

A cross-sectional relationship between vital capacity and diabetes in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Significance of heart rate in the prevalence of metabolic syndrome and its related risk factors in Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Resting heart rate in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Epidemiological aspects of neoplasms in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

Type-2 diabetes and endothelial dysfunction: exploring the road to disease in the reverse direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0309-6

10.1007/S00592-011-0309-6

21 January 2018

Identifiers

DOI

1 reference

release_e3pnhxrdrffklbqb42qfwj4sse

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e3pnhxrdrffklbqb42qfwj4sse

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21720880

1 reference

PubMed ID

21720880